Translational Development...

NASDAQ: TDACU · Real-Time Price · USD
10.36
0.00 (0.00%)
At close: Aug 11, 2025, 2:27 PM
10.36
0.00%
After-hours: Aug 11, 2025, 04:00 PM EDT

Company Description

Trident Acquisitions Corp. is a shell company.

The Company is a blank check company formed for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities.

The Company focuses on identifying a business to a particular industry or geographic region of the world.

The Company is focused on seeking business combination with oil and gas or other natural resources companies in Eastern Europe.

The Company is not engaged in any business operations.

Translational Development Acquisition Corp.
Translational Development Acquisition Corp. logo
Country United States
IPO Date Jan 31, 2022
Industry Shell Companies
Sector Financial Services
Employees n/a
CEO Michael M. B. Hoffman

Contact Details

Address:
77 Water Street
New York City, New York
United States
Website http://www.tridentacquisitions.com

Stock Details

Ticker Symbol TDACU
Exchange NASDAQ
Fiscal Year n/a
Reporting Currency USD
CIK Code 0001673481
CUSIP Number 89615T205
ISIN Number US89615T2050
Employer ID 81-1996183
SIC Code 7372

Key Executives

Name Position
Michael M. B. Hoffman J.D. Chairman of the Board & Chief Executive Officer
Avi C. Das Chief Financial Officer

Latest SEC Filings

Date Type Title
Aug 14, 2025 8-K Current Report
Aug 14, 2025 10-Q Quarterly Report
Aug 07, 2025 8-K Current Report
Jul 31, 2025 SCHEDULE 13G/A [Amend] Filing
Jul 22, 2025 8-K Current Report
Jul 16, 2025 8-K Current Report
Jul 11, 2025 SCHEDULE 13G/A [Amend] Filing
Jul 07, 2025 8-K Current Report
Jul 03, 2025 8-K Current Report
Jul 03, 2025 S-8 POS Filing